BPG is committed to discovery and dissemination of knowledge
Open-Access Journal
Pathophysiological mechanisms involved in non-alcoholic steatohepatitis and novel potential therapeutic targets 
Fátima Higuera-de la Tijera, Alfredo I Servín-Caamaño 
World J Hepatol 7(10):1297-1301. Published online Jun 8, 2015. doi: 10.4254/wjh.v7.i10.1297
Hemodynamic monitoring during liver transplantation: A state of the art review 
Mona Rezai Rudnick, Lorenzo De Marchi, Jeffrey S Plotkin 
World J Hepatol 7(10):1302-1311. Published online Jun 8, 2015. doi: 10.4254/wjh.v7.i10.1302
Targeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patients 
Gul M Mustafa, Denner Larry, John R Petersen, Cornelis J Elferink 
World J Hepatol 7(10):1312-1324. Published online Jun 8, 2015. doi: 10.4254/wjh.v7.i10.1312
Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis 
Licia Polimeni, Maria Del Ben, Francesco Baratta, Ludovica Perri, Fabiana Albanese, Daniele Pastori, Francesco Violi, Francesco Angelico 
World J Hepatol 7(10):1325-1336. Published online Jun 8, 2015. doi: 10.4254/wjh.v7.i10.1325
Liver steatosis in hepatitis C patients 
Emilio González-Reimers, Geraldine Quintero-Platt, Melchor Rodríguez-Gaspar, Remedios Alemán-Valls, Onán Pérez-Hernández, Francisco Santolaria-Fernández 
World J Hepatol 7(10):1337-1346. Published online Jun 8, 2015. doi: 10.4254/wjh.v7.i10.1337
Review on immunosuppression in liver transplantation 
Maryam Moini, Michael L Schilsky, Eric M Tichy 
World J Hepatol 7(10):1355-1368. Published online Jun 8, 2015. doi: 10.4254/wjh.v7.i10.1355
Non-alcoholic fatty liver disease - the heart of the matter 
Haneen Azzam, Stephen Malnick 
World J Hepatol 7(10):1369-1376. Published online Jun 8, 2015. doi: 10.4254/wjh.v7.i10.1369
Chemokines and their receptors play important roles in the development of hepatocellular carcinoma 
Chun-Min Liang, Long Chen, Heng Hu, Hui-Ying Ma, Ling-Ling Gao, Jie Qin, Cui-Ping Zhong 
World J Hepatol 7(10):1390-1402. Published online Jun 8, 2015. doi: 10.4254/wjh.v7.i10.1390
Current concepts in the immunohistochemical evaluation of liver tumors 
Anne K Koehne de Gonzalez, Marcela A Salomao, Stephen M Lagana 
World J Hepatol 7(10):1403-1411. Published online Jun 8, 2015. doi: 10.4254/wjh.v7.i10.1403
Current systemic treatment of hepatocellular carcinoma: A review of the literature 
Kai-Wen Chen, Tzu-Ming Ou, Chin-Wen Hsu, Chi-Ting Horng, Ching-Chang Lee, Yuh-Yuan Tsai, Chi-Chang Tsai, Yi-Sheng Liou, Chen-Chieh Yang, Chao-Wen Hsueh, Wu-Hsien Kuo 
World J Hepatol 7(10):1412-1420. Published online Jun 8, 2015. doi: 10.4254/wjh.v7.i10.1412
Retrospective Study
Alpha-1 antitrypsin deficiency and the risk of hepatocellular carcinoma in end-stage liver disease 
Clara Antoury, Rocio Lopez, Nizar Zein, James K Stoller, Naim Alkhouri 
World J Hepatol 7(10):1427-1432. Published online Jun 8, 2015. doi: 10.4254/wjh.v7.i10.1427
Observational Study
Genetic ancestry analysis in non-alcoholic fatty liver disease patients from Brazil and Portugal 
Lourianne Nascimento Cavalcante, Jose Tadeu Stefano, Mariana V Machado, Daniel F Mazo, Fabiola Rabelo, Kiyoko Abe Sandes, Flair José Carrilho, Helena Cortez-Pinto, Andre Castro Lyra, Claudia P de Oliveira 
World J Hepatol 7(10):1433-1438. Published online Jun 8, 2015. doi: 10.4254/wjh.v7.i10.1433